SEC 13F Intelligence

Highline Capital Management, L.P. / RGNX

Highline Capital Management, L.P.’s Regenxbio Inc Position

Does Highline Capital Management, L.P. own Regenxbio Inc (RGNX)? Not currently — the last reported position was 180.6K shares worth $10M in Q1 2019; the fund’s latest 13F (Q4 2022) no longer reports it.

Position Value
$10M
Q1 2019
Shares
180.6K
% of Portfolio
+0.65%
Quarters Held
1
position exited

Position History RGNX

Reported value by quarter
Q1 ’19: $10MQ1 ’19filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2019180.6K$10M+0.65%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Highline Capital Management, L.P.’s full portfolio or all institutional holders of RGNX.